Cargando…
Is it justified to assess the resectability of pancreatic cancer combined with biological and conditional factors?
BACKGROUND: This study aimed to investigate the biological and conditional resectability criteria for pancreatic ductal adenocarcinoma (PDAC), as proposed by the International Association of Pancreatology (IAP), as well as to identify the role of biological and conditional factors in assessing the r...
Autores principales: | Huang, Bingying, Geng, Hao, Jin, Yun, Zhang, Xiaoxiao, Qian, Hai, Ye, Dan, Wu, Jinhong, Zhu, Huanbing, Yu, Yuanquan, Zhou, Donger, Li, Jiangtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641078/ https://www.ncbi.nlm.nih.gov/pubmed/36388054 http://dx.doi.org/10.21037/tcr-22-1258 |
Ejemplares similares
-
MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4
por: Liu, Daren, et al.
Publicado: (2022) -
Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
por: Wang, Zhiwei, et al.
Publicado: (2021) -
Is combined extra-hepatic bile-duct resection justified for advanced gallbladder carcinoma?
por: Wang, Jun-Ke, et al.
Publicado: (2019) -
Lactate promotes the growth of patient-derived organoids from hepatopancreatobiliary cancers via ENO1/HIF1α pathway and does not affect their drug sensitivities
por: Wang, Zhiwei, et al.
Publicado: (2022) -
Is Repeated Hepatic Resection Justified for Malignancy?
por: Sugarbaker, Paul H.
Publicado: (1991)